利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

273 条记录 (耗时 0.013 秒)

    Process for the manufacture of .alpha.-chloracetoacetamides
    2.
    发明授权
    Process for the manufacture of .alpha.-chloracetoacetamides 失效
    制备α-氯乙酰乙酰胺的方法

    公开(公告)号：US4207259A

    公开(公告)日：1980-06-10

    申请号：US42700

    申请日：1979-05-25

    申请人： Gerhard Kunstle ,  Herbert Jung

    发明人： Gerhard Kunstle ,  Herbert Jung

    IPC分类号： C07C67/00 ,  C07C231/00 ,  C07C231/12 ,  C07C235/80 ,  C07C103/30

    CPC分类号： C07C231/00

    摘要： According to the invention, .alpha.-chloracetoacetamides, which is to be understood as including both .alpha.-chloro-N-monoalkylacetoacetamides and .alpha.-chloro-N,N-dialkylacetoacetamides, the alkyl radicals of which contain 1 to 3 carbon atoms, are produced by reacting the corresponding acetoacetamides with chlorine in aqueous solution at temperatures in the range of from -1.degree. C. to -25.degree. C. At a conversion of at least 95%, a selectivity of at least 97% and a yield of at least 95% of the theoretical yield, calculated on reacted acetoacetamide, are obtained.

    摘要翻译： 根据本发明，α-氯乙酰乙酰胺应理解为包括α-氯-N-单烷基乙酰乙酰胺和α-氯-N，N-二烷基乙酰乙酰胺，其烷基含有1至3个碳原子，由 使相应的乙酰乙酰胺与水溶液中的氯反应，温度范围为-1℃至-25℃。转化率至少为95％，选择性至少为97％，产率至少为95 获得按反应的乙酰乙酰胺计算的理论产率的％。

    Preparation of formamide compounds
    4.
    发明授权
    Preparation of formamide compounds 失效
    甲酰胺化合物的制备

    公开(公告)号：US3997605A

    公开(公告)日：1976-12-14

    申请号：US578460

    申请日：1975-05-19

    申请人： Roger J. Hopper

    发明人： Roger J. Hopper

    IPC分类号： C07C313/08 ,  C07C103/02 ,  C07C103/30

    CPC分类号： C07C313/08

    摘要： N-cyclohexyl-formamide is reacted with sulfur monochloride in the presence of an organic hydrogen chloride acceptor to form N,N'-di(cyclohexyl)-N,N'-dithiobis(formamide), which can then be reacted with sulfuryl chloride or chlorine to form N-chlorothio-N-cyclohexyl-formamide which can then be reacted with an olefin to form a retarder having the following structural formula. ##STR1##

    摘要翻译： N-环己基甲酰胺与一氯化硫在有机氯化氢受体存在下反应形成N，N'-二（环己基）-N，N'-二硫代双（甲酰胺），然后与硫酰氯或 氯以形成N-氯代硫代-N-环己基甲酰胺，然后将其与烯烃反应以形成具有以下结构式的延迟剂。

    Radioactive functional diagnostic agents
    5.
    发明授权
    Radioactive functional diagnostic agents 失效
    放射性功能诊断剂

    公开(公告)号：US3939204A

    公开(公告)日：1976-02-17

    申请号：US366461

    申请日：1973-06-04

    申请人： Gotz Buttermann

    发明人： Gotz Buttermann

    IPC分类号： G21H5/02 ,  C07B31/00 ,  C07B59/00 ,  C07C67/00 ,  C07C231/00 ,  C07C231/12 ,  C07C233/54 ,  C07C235/16 ,  C07C237/46 ,  C07C103/30

    摘要： This invention relates to triiodized dicarboxylic acid anilides containing radioactive iodine of the formula ##SPC1##WhereinR.sub.1 is hydrogen, carboxyl, N-acylamino, N-acylaminomethyl, N-alkyl-N-acylamino, N-butyrolactamyl, or an ##EQU1## group, wherein R.sub.3 and R.sub.4 are each hydrogen, lower alkyl or hydroxyalkyl, or R.sub.3 and R.sub.4 together with the nitrogen atom form a 5 to 7 member heterocyclic ring which can contain a further oxygen, nitrogen or sulfur hetero atom;R.sub.2 is hydrogen, lower alkyl or hydroxyalkyl; andX is straight-chain or branched alkylene of 1-14 carbon atoms, which can be interrupted by one or more oxygen or sulfur atoms,As well as the physiologically acceptable salts thereof with suitable bases. These compounds are especially useful in the preparation of radioactive functional diagnostic agents.

    摘要翻译： 本发明涉及含有下列化学式的放射性碘的三碘化二羧酸二酰苯酯：其中R1是氢，羧基，N-酰基氨基，N-酰基氨基甲基，N-烷基-N-酰基氨基，N-丁基内酰胺基或R3-ANGLEN-CO R4基团 其中R3和R4各自为氢，低级烷基或羟基烷基，或R3和R4与氮原子一起形成可含有另外的氧，氮或硫杂原子的5至7元杂环; R2是氢，低级烷基或羟烷基; X是1-14个碳原子的直链或支链亚烷基，其可以被一个或多个氧原子或硫原子间隔，如同具有适当基础的生物学上可接受的盐。 这些化合物特别可用于制备放射性功能诊断剂。

    Quaternary ammonium salts of n-substituted palmitamides
    10.
    发明授权
    Quaternary ammonium salts of n-substituted palmitamides 失效
    N-取代的棕榈酰胺的季铵盐

    公开(公告)号：US3869483A

    公开(公告)日：1975-03-04

    申请号：US26586972

    申请日：1972-06-23

    申请人： US AGRICULTURE

    发明人： MOD ROBERT R ,  MAGNE FRANK C ,  SKAU EVALD L ,  SUMRELL GENE

    IPC分类号： C07D295/185 ,  C07C103/30

    CPC分类号： C07D295/185

    摘要： A number of new quaternary ammonium salts of n-substituted palmitamides have been prepared by conventional methods. These derivatives have been characterized by exhibiting antimycotic activity and three of the derivatives, 4-palmitoyl-1,1dimethylpiperazinium iodide, (2palmitoylaminoethyl)trimethylammonium iodide, and 4-palmitoyl-1methyl-1-(1,4,5,6,7,7-hexachlorobicyclo(2.2.1)-hepta-2,5-diene -2methylene)piperazinium bromide have been further characterized by exhibiting nematocidal activity.

    摘要翻译： 已经通过常规方法制备了许多新的N-取代的棕榈酰胺季铵盐。 这些衍生物的特征在于显示出抗真菌活性，并且三种衍生物，4-棕榈酰基-1,1-二甲基哌嗪鎓碘化物，（2-棕榈酰氨基乙基）三甲基碘化铵和4-棕榈酰-1-甲基-1-（1,4， 5,6,7,7-六氯双环[2.2.1] - 庚-2,5-二烯-2-亚甲基）哌嗪鎓溴化物的进一步特征在于具有杀线虫活性。